Adagio Pharmaceuticals, Cynapsus deal

Adagio granted Cynapsus (formerly Cannasat Therapeutics Inc.) an exclusive option for exclusive, worldwide rights to develop and commercialize Adagio's APL-130277. The small molecule dopamine recept...